National Health Investors (NHI)
(Delayed Data from NYSE)
$72.10 USD
-0.28 (-0.39%)
Updated Jul 19, 2024 04:00 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NHI 72.10 -0.28(-0.39%)
Will NHI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for NHI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NHI
National Health Investors (NHI) Is Up 3.44% in One Week: What You Should Know
Is It Wise to Hold Healthpeak Properties (DOC) Stock Now?
NHI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?
Are You Looking for a Top Momentum Pick? Why National Health Investors (NHI) is a Great Choice
National Health Investors (NHI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for NHI
NHI Dividend Yield Pushes Above 5%
Ex-Dividend Reminder: National Health Investors, CareTrust REIT and Sunstone Hotel Investors
National Health Investors price target raised by $8 at Truist, here's why
National Health Investors (NHI) Receives a Hold from Truist Financial
National Health Investors Reaches Analyst Target Price